SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India board to consider third interim dividend

20 Jan 2017 Evaluate

Granules India has informed that the meeting of the Board of Directors of the Company is scheduled to be held on January 28, 2017, to consider and approve the Un-audited Financial Results for the third quarter ended December 31, 2016 and the payment of third interim dividend for the FY 2016-17, if any. Further, the Company has informed that Insider Trading Window of Granules India is closed from January 20, 2017 to January 30, 2017 in view of the above mentioned Board Meeting.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

854.40 21.25 (2.55%)
06-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1913.05
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.05
Lupin 2492.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: